Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
MARKER FOR DETERMINING CRITICAL STAGE KIDNEY DISEASE
Document Type and Number:
WIPO Patent Application WO/2020/080488
Kind Code:
A1
Abstract:
The present invention provides: a marker for determining critical stage kidney disease by using an indicator value based on the amount of D-alanine in the blood or the amount of D-alanine and L-alanine therein; a blood analysis method which uses said marker for patients undergoing surgery or intensive care; and a blood analysis system for determining critical stage kidney disease in patients undergoing surgery or intensive care.

Inventors:
MITA MASASHI (JP)
WADA TAKASHI (JP)
FURUICHI KENGO (JP)
SAKAI NORIHIKO (JP)
IWATA YASUNORI (JP)
KITAJIMA SHINJI (JP)
NAKADE YUSUKE (JP)
Application Number:
PCT/JP2019/040968
Publication Date:
April 23, 2020
Filing Date:
October 17, 2019
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SHISEIDO CO LTD (JP)
UNIV NAT CORP KANAZAWA (JP)
International Classes:
G01N33/68; G01N33/48; G01N33/70
Foreign References:
JP2015132598A2015-07-23
Other References:
SUZUKI MASATAKA ET AL.: "Diseases and D-amino acids: potential as biomarkers", SEIBUTSU KOGAKU, vol. 92, 2014, pages 661 - 664
KIMURA, T. ET AL.: "Chiral amino acid metabolomics for novel biomarker screening in the prognosis of chronic kidney disease", SCIENTIFIC REPORTS, vol. 6, May 2016 (2016-05-01), pages 1 - 7, XP055371897
NAKADE, Y. ET AL.: "Gut microbiota-derived D-serine protects against acute kidney injury", JCI INSIGHT, vol. 3, no. 20, 18 October 2018 (2018-10-18), pages 1 - 16, XP055662467, DOI: 10.1172/jci.insight.97957
Attorney, Agent or Firm:
AOKI, Atsushi et al. (JP)
Download PDF: